drugset / Trial / NCT02822937
Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents
RandomizedSingle-groupDouble-blindBasic science
Summary
This is a study in adults to assess the sensitivity of Project: EVO Monitor cognitive measurements to two short-acting cognitively active pharmacological agents. The participants will receive a placebo, and two pharmacological agents in a randomized order for three in-clinic study days. During each study day in the clinic, the participants will use Project: EVO Monitor and another cognitive task through the day.
Timeline
- Start
- 2016-07
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 40 mg | — |
| Subject | Triazolam | Small molecule | 0.375 mg | — |
Indications
No indication recorded.